Value Bridge — TUFTS MEDICAL CENTER
Current $-41M → Target $-23M (+$18.1M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-41.0M
Current EBITDA
$-22.9M
Target EBITDA
+$18.1M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$4.1M
Payer Mix Optimization
$9.8M
Cost to Collect Reduction
$3.3M
Clean Claim Improvement
$2.5M
Volume & Rate Growth
$16.4M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-41M to $-23M. The highest-impact lever is Volume & Rate Growth at $6.6M probability-weighted.
IC talking point: "We see $18M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $199M in equity value creation."